ATLANTA, Apr 23, 2012 (BUSINESS WIRE) –
, today announced
that the necessary revenue numbers for its fourth quarter are not yet
available to include in its Fiscal 2011 10-K annual report for the
fiscal year ending Dec. 31, 2011 due to a required change in GeneLink
Biosciences, Inc. auditors.
On Feb. 16, Capsalus had announced the completed acquisition of the
stock of GeneWize Life Sciences, Inc., the wholly-owned direct-selling
subsidiary of GeneLink Biosciences, a leader in consumer genomics. The
deal provided immediate revenues.
Due to the unavailability of the fourth quarter audited financials, an
“E” symbol was placed on Capsalus’ ticker symbol by the OTC Bulletin
Board, informing the company that it had 30 days to file the annual
report. Capsalus is actively working with the new auditors at GeneLink
to have the “E” symbol removed as quickly as possible.
For more information about Capsalus, visit
or call 888-400-7179.
Capsalus Corp. (
partners with and acquires visionary enterprises in the health and
wellness space producing progressive, broad-based solutions for better
physical, nutritional and emotional health worldwide. Capsalus, which
derives its name from “Salus,” the Roman goddess of health and
prosperity, works with companies in varying stages of development, from
consumer products to media and technology and biotechnology. It provides
operating infrastructure, strategic pathways and financial support to
get them to the